Acro Biomedical Co. Ltd. (ACBM)
0.026
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Acro Biomedical EPS Diluted (Quarterly) : -0.0004 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0004 |
| March 31, 2026 | -0.0007 |
| December 31, 2025 | 0.0007 |
| September 30, 2025 | -0.002 |
| June 30, 2025 | -0.0003 |
| March 31, 2025 | -0.0002 |
| December 31, 2024 | -0.0002 |
| September 30, 2024 | -0.0002 |
| June 30, 2024 | -0.0002 |
| March 31, 2024 | -0.0002 |
| December 31, 2023 | -0.0003 |
| September 30, 2023 | -0.0265 |
| June 30, 2023 | -0.0532 |
| March 31, 2023 | -0.0667 |
| December 31, 2022 | -0.0655 |
| September 30, 2022 | -0.0668 |
| June 30, 2022 | -0.0666 |
| March 31, 2022 | -0.0654 |
| December 31, 2021 | -0.0642 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.0526 |
| June 30, 2021 | -0.0157 |
| March 31, 2021 | -0.0012 |
| December 31, 2020 | -0.0013 |
| September 30, 2020 | -0.0015 |
| June 30, 2020 | -0.0013 |
| March 31, 2020 | 0.0017 |
| December 31, 2019 | -0.0016 |
| September 30, 2019 | -0.0016 |
| June 30, 2019 | -0.0011 |
| March 31, 2019 | -0.0036 |
| September 30, 2018 | 0.0032 |
| June 30, 2018 | 0.0024 |
| March 31, 2018 | 0.0015 |
| December 31, 2017 | 0.0017 |
| September 30, 2017 | 0.0008 |
| June 30, 2017 | -0.0002 |
| March 31, 2017 | -0.0005 |
| December 31, 2016 | -0.0002 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | -0.0002 |
| Xcelerate, Inc. | -0.0001 |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Vivos Therapeutics, Inc. | -0.31 |
| Stella Diagnostics, Inc. | -0.0032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.0214M |
| Total Expenses (Quarterly) | 0.0214M |
| Enterprise Value | 1.943M |
| Earnings Yield | -9.23% |
| Normalized Earnings Yield | -12.69 |